Novolog Mix 70/30
NDC Package 50090-2273-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Novolog Mix 70/30 is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in adult patients with diabetes mellitus.Limitations of Use:•NOVOLOG MIX 70/30 is not recommended for the treatment of diabetic ketoacidosis.•The proportions of rapid-acting and long-acting insulins in NOVOLOG MIX 70/30 are fixed and do not allow for basal versus prandial dose adjustments. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-2273 and is authorized under FDA application BLA021172.

Identification & Billing

NDC Package Code
50090-2273-0
Package Description
1 VIAL, GLASS in 1 CARTON / 10 mL in 1 VIAL, GLASS
Product Code
50090-2273
11-Digit Billing Format
50090227300
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 351297 - insulin aspart protamine / insulin aspart 70/30 Injectable Suspension
  • RxCUI: 351297 - insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension
  • RxCUI: 351297 - insulin analog, aspart mixed 70/30 100 UNT/ML Injectable Suspension
  • RxCUI: 847191 - insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector
  • RxCUI: 847191 - 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector

Clinical Specifications

Proprietary Name
Novolog Mix 70/30
Dosage Form
-
Usage Information
NOVOLOG MIX 70/30 is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in adult patients with diabetes mellitus.Limitations of Use:•NOVOLOG MIX 70/30 is not recommended for the treatment of diabetic ketoacidosis.•The proportions of rapid-acting and long-acting insulins in NOVOLOG MIX 70/30 are fixed and do not allow for basal versus prandial dose adjustments.

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
FDA Application #
BLA021172
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
11-01-2001
End Marketing Date
12-31-2023
Listing Expiration
12-31-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-2273-0 identifies a specific commercial package of 1 vial, glass in 1 carton / 10 ml in 1 vial, glass of Novolog Mix 70/30, labeled by A-s Medication Solutions. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on November 01, 2001. The current certification is valid through December 31, 2023.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090227300. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-2273-0
11-Digit CMS (5-4-2)
50090-2273-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.